Plunkett Research Online: OncoVista Innovative Therapies Inc

ONCOVISTA INNOVATIVE THERAPIES INC (OVIT:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

OncoVista Innovative Therapies, Inc. is a biopharmaceutical company engaged in the commercialization of diagnostic tests for metastatic tumors, as well as the development of targeted anticancer therapies by utilizing tumor-associated biomarkers. The company has developed diagnostic kits for breast, .....



OncoVista Innovative Therapies Inc
Ticker: OVIT
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 210 677-6000
Fax:
Address: 14785 Omicron Drive
Suite 104
San Antonio, TX 78245 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Cancer Diagnostics
Cancer Therapies
ContactsDescription
Alexander WeisCEO/CFO/Chairman of the Board/Chief Accounting Officer/Director/President/Secretary
Michael MoloneyCOO
See More
OncoVista Innovative Therapies, Inc. is a biopharmaceutical company engaged in the commercialization of diagnostic tests for metastatic tumors, as well as the development of targeted anticancer therapies by utilizing tumor-associated biomarkers. The company has developed diagnostic kits for breast, .....See More See More

Auditor: GHP Horwath, P.C.
Legal Advisor: Oswald & Yap LLP
$USD, In whole numbers,
except marked * or %
201420132012201120102009
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: